Is Tonix Pharmaceuticals Holding Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Tonix Pharmaceuticals Holding Corp (TNXP) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Tonix Pharmaceuticals Holding Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tonix Pharmaceuticals Holding Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Tonix Pharmaceuticals Holding Corp?

Muslim investors may consider investing in Tonix Pharmaceuticals Holding Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Tonix Pharmaceuticals Holding Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Tonix Pharmaceuticals Holding Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Tonix Pharmaceuticals Holding Corp updated?

The Shariah compliance status of Tonix Pharmaceuticals Holding Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Tonix Pharmaceuticals Holding Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Tonix Pharmaceuticals Holding Corp?

You can check the latest Shariah compliance status of Tonix Pharmaceuticals Holding Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TNXP Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 16, 2026

Report Source: 2025 Annual Report

Tonix Pharmaceuticals Holding Corp. Stock Analysis TNXP

United States Health Care Micro Cap Report: 2025 Annual

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. The company is headquartered in Chatham, New Jersey and currently employs 142 full-time employees. The company went IPO on 2010-03-29. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. The company markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Key Statistics of Tonix Pharmaceuticals Holding Corp (TNXP)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$13.50$15.82

Today's Open

$13.71

Volume

724.66K

P/E Ratio (TTM)

52 Week Range

$11.60$69.97

Market Cap

191.77M

Avg. Volume

412.18K

Dividend Yield

Financial Metrics & Statements of Tonix Pharmaceuticals Holding Corp (TNXP)

FAQ's for Tonix Pharmaceuticals Holding Corp (TNXP)

According to Musaffa’s Shariah screening methodology, Tonix Pharmaceuticals Holding Corp (TNXP) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.